000 01658 a2200505 4500
005 20250516013841.0
264 0 _c20110603
008 201106s 0 0 eng d
022 _a1365-2036
024 7 _a10.1111/j.1365-2036.2010.04523.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKopylov, U
245 0 0 _aThe efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab.
_h[electronic resource]
260 _bAlimentary pharmacology & therapeutics
_cFeb 2011
300 _a349-57 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aCrohn Disease
_xdrug therapy
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aGastrointestinal Agents
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aInfliximab
650 0 4 _aMale
650 0 4 _aRetrospective Studies
650 0 4 _aStatistics as Topic
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aMantzaris, G J
700 1 _aKatsanos, K H
700 1 _aReenaers, C
700 1 _aEllul, P
700 1 _aRahier, J F
700 1 _aIsraeli, E
700 1 _aLakatos, P L
700 1 _aFiorino, G
700 1 _aCesarini, M
700 1 _aTsianos, E V
700 1 _aLouis, E
700 1 _aBen-Horin, S
773 0 _tAlimentary pharmacology & therapeutics
_gvol. 33
_gno. 3
_gp. 349-57
856 4 0 _uhttps://doi.org/10.1111/j.1365-2036.2010.04523.x
_zAvailable from publisher's website
999 _c20410631
_d20410631